BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18311836)

  • 21. A comprehensive analysis of shared loci between systemic lupus erythematosus (SLE) and sixteen autoimmune diseases reveals limited genetic overlap.
    Ramos PS; Criswell LA; Moser KL; Comeau ME; Williams AH; Pajewski NM; Chung SA; Graham RR; Zidovetzki R; Kelly JA; Kaufman KM; Jacob CO; Vyse TJ; Tsao BP; Kimberly RP; Gaffney PM; Alarcón-Riquelme ME; Harley JB; Langefeld CD;
    PLoS Genet; 2011 Dec; 7(12):e1002406. PubMed ID: 22174698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations between Klinefelter's syndrome and autoimmune diseases: English national record linkage studies.
    Seminog OO; Seminog AB; Yeates D; Goldacre MJ
    Autoimmunity; 2015 Mar; 48(2):125-8. PubMed ID: 25295757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of dendritic cell immunoreceptor (DCIR) polymorphisms in susceptibility of systemic lupus erythematosus and primary Sjogren's syndrome.
    Liu M; Wu X; Liu X; He J; Su Y; Guo J; Li Z
    Hum Immunol; 2015 Nov; 76(11):808-11. PubMed ID: 26429306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of patients with systemic lupus erythematosus (SLE) and non-Hodgkin's lymphoma (NHL).
    King JK; Costenbader KH
    Clin Rheumatol; 2007 Sep; 26(9):1491-4. PubMed ID: 17297594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers.
    Chatterjee N; Hartge P; Cerhan JR; Cozen W; Davis S; Ishibe N; Colt J; Goldin L; Severson RK
    Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1415-21. PubMed ID: 15342441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biosemantics guided gene expression profiling of Sjögren's syndrome: a comparative analysis with systemic lupus erythematosus and rheumatoid arthritis.
    Shah NR; Noll BD; Stevens CB; Brennan MT; Mougeot FB; Mougeot JC
    Arthritis Res Ther; 2017 Aug; 19(1):192. PubMed ID: 28818099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor necrosis factor-α induced protein 8 polymorphism and risk of non-Hodgkin's lymphoma in a Chinese population: a case-control study.
    Zhang Y; Wang MY; He J; Wang JC; Yang YJ; Jin L; Chen ZY; Ma XJ; Sun MH; Xia KQ; Hong XN; Wei QY; Zhou XY
    PLoS One; 2012; 7(5):e37846. PubMed ID: 22666399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjögren's syndrome.
    Du Y; Su Y; He J; Yang Y; Shi Y; Cui Y; Luo C; Wu X; Liu X; Hu F; Ma X; Zheng L; Zhang J; Zuo X; Sheng Y; Wu L; Zhang X; Guo J; Li Z
    Ann Rheum Dis; 2015 Nov; 74(11):2070-5. PubMed ID: 24906639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Summary on the Genetics of Systemic Lupus Erythematosus, Rheumatoid Arthritis, Systemic Sclerosis, and Sjögren's Syndrome.
    Ortíz-Fernández L; Martín J; Alarcón-Riquelme ME
    Clin Rev Allergy Immunol; 2023 Jun; 64(3):392-411. PubMed ID: 35749015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoimmune thyroid disease is associated with a diagnosis of secondary Sjögren's syndrome in familial systemic lupus.
    Scofield RH; Bruner GR; Harley JB; Namjou B
    Ann Rheum Dis; 2007 Mar; 66(3):410-3. PubMed ID: 16984944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for non-Hodgkin's lymphoma according to family history of haematolymphoproliferative malignancies.
    Zhu K; Levine RS; Brann EA; Gu Y; Caplan LS; Hall I; Baum MK
    Int J Epidemiol; 2001 Aug; 30(4):818-24. PubMed ID: 11511610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequency of Polyautoimmunity in Patients With Rheumatoid Arthritis and Systemic Lupus Erythematosus.
    Ordoñez-Cañizares MC; Mena-Vázquez N; Redondo-Rodriguez R; Manrique-Arija S; Jimenez-Núñez FG; Ureña-Garnica I; Fernández-Nebro A
    J Clin Rheumatol; 2022 Jan; 28(1):e38-e43. PubMed ID: 32956154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A missense variant in NCF1 is associated with susceptibility to multiple autoimmune diseases.
    Zhao J; Ma J; Deng Y; Kelly JA; Kim K; Bang SY; Lee HS; Li QZ; Wakeland EK; Qiu R; Liu M; Guo J; Li Z; Tan W; Rasmussen A; Lessard CJ; Sivils KL; Hahn BH; Grossman JM; Kamen DL; Gilkeson GS; Bae SC; Gaffney PM; Shen N; Tsao BP
    Nat Genet; 2017 Mar; 49(3):433-437. PubMed ID: 28135245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Family history of hematopoietic malignancy and risk of lymphoma.
    Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
    J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A BAFF receptor His159Tyr mutation in Sjögren's syndrome-related lymphoproliferation.
    Papageorgiou A; Mavragani CP; Nezos A; Zintzaras E; Quartuccio L; De Vita S; Koutsilieris M; Tzioufas AG; Moutsopoulos HM; Voulgarelis M
    Arthritis Rheumatol; 2015 Oct; 67(10):2732-41. PubMed ID: 26097183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes.
    Din L; Sheikh M; Kosaraju N; Smedby KE; Bernatsky S; Berndt SI; Skibola CF; Nieters A; Wang S; McKay JD; Cocco P; Maynadié M; Foretová L; Staines A; Mack TM; de Sanjosé S; Vyse TJ; Padyukov L; Monnereau A; Arslan AA; Moore A; Brooks-Wilson AR; Novak AJ; Glimelius B; Birmann BM; Link BK; Stewart C; Vajdic CM; Haioun C; Magnani C; Conti DV; Cox DG; Casabonne D; Albanes D; Kane E; Roman E; Muzi G; Salles G; Giles GG; Adami HO; Ghesquières H; De Vivo I; Clavel J; Cerhan JR; Spinelli JJ; Hofmann J; Vijai J; Curtin K; Costenbader KH; Onel K; Offit K; Teras LR; Morton L; Conde L; Miligi L; Melbye M; Ennas MG; Liebow M; Purdue MP; Glenn M; Southey MC; Din M; Rothman N; Camp NJ; Wong Doo N; Becker N; Pradhan N; Bracci PM; Boffetta P; Vineis P; Brennan P; Kraft P; Lan Q; Severson RK; Vermeulen RCH; Milne RL; Kaaks R; Travis RC; Weinstein SJ; Chanock SJ; Ansell SM; Slager SL; Zheng T; Zhang Y; Benavente Y; Taub Z; Madireddy L; Gourraud PA; Oksenberg JR; Cozen W; Hjalgrim H; Khankhanian P
    Genet Epidemiol; 2019 Oct; 43(7):844-863. PubMed ID: 31407831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VDR Polymorphisms in Autoimmune Connective Tissue Diseases: Focus on Italian Population.
    Latini A; De Benedittis G; Perricone C; Colafrancesco S; Conigliaro P; Ceccarelli F; Chimenti MS; Novelli L; Priori R; Conti F; Ciccacci C; Borgiani P
    J Immunol Res; 2021; 2021():5812136. PubMed ID: 34977255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK.
    Conrad N; Misra S; Verbakel JY; Verbeke G; Molenberghs G; Taylor PN; Mason J; Sattar N; McMurray JJV; McInnes IB; Khunti K; Cambridge G
    Lancet; 2023 Jun; 401(10391):1878-1890. PubMed ID: 37156255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NcoI restriction fragment length polymorphism (RFLP) of the tumor necrosis factor (TNF alpha) region in four autoimmune diseases.
    Fugger L; Morling N; Ryder LP; Georgsen J; Jakobsen BK; Svejgaard A; Andersen V; Oxholm P; Karup Pedersen F; Friis J
    Tissue Antigens; 1989 Jul; 34(1):17-22. PubMed ID: 2573169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The importance of microRNAs in the development of systemic autoimmune disorders].
    Jámbor I; Szabó K; Zeher M; Papp G
    Orv Hetil; 2019 Apr; 160(15):563-572. PubMed ID: 30957538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.